Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection
CA 2720384 C · Owner: Institut Pasteur · Inventors: Guesdon, Jean-Luc; Denoyelle-Gryson, Francoise; Petit, Christine
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence which in a wild form encodes a polypeptide implicated in hereditary sensory defect wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 14, 1998 and granted August 12, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 14, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 14, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.